Investigating COPD prevalence in socially vulnerable individuals using a mobile clinic
Official title: A Study of the Incidence and Treatment of Impaired Lung Function Among Socially Vulnerable Individuals at a Street Level
Run by Hvidovre University Hospital · NCT05660460 · Data updated 2026-11-12
This study looks at how common Chronic Obstructive Pulmonary Disease (COPD) is among people in need who visit a mobile clinic in Denmark to see if they have it more often than others and to learn about their experiences with screening and treatment.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 511 (estimated) |
| Sponsor | Hvidovre University Hospital Academic / other |
| Locations | 1 site (Copenhagen) |
| Status | Recruiting |
| Started | March 15, 2023 |
| Main results expected | March 15, 2027 |
| Study ends | January 31, 2029 |
| Registry record updated | April 9, 2024 |
| Trial ID | NCT05660460 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are individuals aged 18 and older who are socially vulnerable, including those affected by homelessness, drug abuse, or mental illness.
✕Probably not a fit
Patients who do not have a Danish civil registration number or are unable to communicate in Danish or English may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This trial examines the prevalence of Chronic Obstructive Pulmonary Disease (COPD) among socially vulnerable individuals who interact with a mobile clinic in the Capital Region of Denmark. It consists of three sub-studies: a cross-sectional study to assess COPD prevalence, a cohort study to evaluate the impact of opportunistic screening, and a qualitative study to understand patient experiences with screening and treatment. The study aims to highlight the higher incidence of COPD in this population compared to the general public and monitor significant variables related to treatment and health outcomes over a year.
Why it matters
Potential benefit: If successful, this study could lead to improved screening and treatment strategies for COPD in socially vulnerable populations.
How similar studies have gone: Other studies have indicated that targeted screening in vulnerable populations can yield significant health insights, suggesting potential success for this approach.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * 18 years or older * Able to speak and understand Danish or English to such an extent that informed consent can be obtained Exclusion Criteria: \- Not having a Danish civil registration number, since foreign patients do not have free access to examinations and medical treatment, and cannot be followed up in the national patient registry
Where it's running
-
Brugernes Akademi
Copenhagen, Denmark Recruiting
Study contacts
- Principal investigator: Charlotte S Ulrik — Amager and Hvidovre Hospital
- Study coordinator: Jannet van der Veen
- Email: jannet@brugernesakademi.dk
- Phone: +45 21157392
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
AERO-007: a inhaled LABA+LAMA combination for COPD through a nebulizer
This study tests whether a nebulized LABA+LAMA combination can improve lung function in adults with COPD.
-
Cognitive load and inhaler technique in COPD
This study tests whether adding a short memory task while using an inhaler makes COPD patients more likely to misuse their inhaler.
-
Balance training after pulmonary rehab for COPD to help steadiness and reduce falls
A COPD-focused balance training program called Sport4Steadiness is being tested to see if people with COPD will accept it and if the study processes work well.
-
Continuous vs High-Intensity Interval Exercise in COPD
This study tests whether continuous versus high-intensity interval exercise affects cerebral oxygenation in people with COPD.
-
Biomarker clues for COPD, IPF, and lung cancer
This study tests whether inflammation, immune, genetic, and epigenetic markers at enrollment can explain how COPD, IPF, or lung cancer present and behave, in order to see if these markers can predict outcomes over a year.
-
HRS-9821 Inhalation Suspension for COPD: Safety and Dose Finding in Adults
This study tests whether HRS-9821 inhalation can be safely taken and help people with moderate to severe COPD, and aims to find a reasonable dose.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.